Our Event Co-Chairs
Yu Ming Dammann
Senior Associate General Counsel, Head of Intellectual Property
Kite Pharmaceuticals Inc
Dr. Leslie Fischer
Principal Patent Attorney
Sandoz
Leslie Fischer is a Principal Patent Attorney at Sandoz, who focuses on global IP strategy for biosimilars. Before joining Sandoz, Leslie was a patent attorney at Novartis Pharmaceuticals, where she worked for over a decade developing global patent portfolios for biologicals. Before joining the Novartis group, Leslie was an associate at Fitzpatrick Cella (NY) (now Venable). Leslie holds a J.D. from Rutgers University and a Ph.D. in Biochemistry from Thomas Jefferson University. Her scientific work appears in JCB, JBC, and Osteoarthritis & Cartilage. She speaks frequently at patent-related events and is an adjunct professor at Seton Hall Law School.
Paul Inman
Partner
Gowling
With more than 25 years' experience of litigating intellectual property (IP) disputes both within the UK and internationally, Paul Inman works with companies ranging from small start-ups to major multi-national corporations. He specialises in the life sciences sector, which includes acting on high-profile pharmaceutical patent infringement cases in the UK Patents Court.
Paul provides life science businesses with commercial advice from an international outlook. His specialist experience ideally places him to provide this expertise and client care, with the ultimate aim of delivering well-rounded advice and guidance to ensure the best possible outcome.
As well as litigating in the English courts, he has co-ordinated and advised on IP and regulatory litigation matters across the globe; from all over Europe and the US, to as far afield as Asia, South Africa, Australia and New Zealand.
Successfully guiding clients through the maze of litigation is where Paul's strength lies, having now been involved over 25 years of litigation in cases leading to more than 40 reported judgments. These range from the tribunals of the UK Patent Office up to the House of Lords, European Patent Office and European Court of Justice.
Paul also has a degree in Molecular Biology and Biochemistry and during his professional career has established an outstanding reputation in the market. He is distinguished in the 2023 edition of IAM Patent 1000: The World's Leading Patent Professionals, ranked individually for both IP law and life sciences law in the peer review publication 'Best Lawyers® in the UK' and recognised in several categories within Chambers & Partners UK 2023.
Martina Tyreus Hufnal
Principal
F&R
What Are We Bringing In October?
Unlike any other patent litigation events in the U.S, this industry-led event has been carefully curated alongside in-house counsels from innovator, generic, biologic and biosimilar organisations to determine latest patent litigation frontiers shaping the U.S. jurisdiction and further afield. 
VIEW THE FULL PROGRAM
Highlights For This Year Include
- BPCIA Litigation Review: Discover the latest in Innovator vs Biosimilar litigation in the USA
- Enablement and Plausibility: Seek out the outcome of Amgen vs Sanofi and how it is shaping inhouse patent litigation strategy
- Obviousness Type Double Patenting: Enhance your patent extension strategy with an updated approach towards PTAs and PTEs
- Share your views at Patent Litigation Strategy 24 Roundtables: Trade Secret – ADC – Next-Gen Therapeutics: benchmark and share your views on the latest patent protection strategy.
- Skinny Label Case Law Review: Understand the Latest Strategies and Updates from Novartis and Recordati
150+
Attendees
40+
Leading Top Speakers
12+
Dedicated Networking Hours
50%
In-House General Counsel
With a full slate of main-stage keynotes, breakout sessions, networking and more across three jam-packed days, you and your team will gain the connections and insights you need across three key pillars.
Interested in how you can get involved with Pharma & Biotech Patent Litigation North America 2024?
Based on your objectives, we can create bespoke packages for you. From presenting your expertise on stage to partnering with us to deliver networking activities. Partner with us in 2024 to showcase your brand and make valuable new connections. Opportunities include thought leadership, branding, and networking.
Discuss your objectives with Duncan Henderson, Commercial Partnerships Director, [email protected]
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.